3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma XBOT

Realbotix Corp.

XBOT TSXV Biotech & Pharma

Stock factsheet

TickerXBOT
ExchangeTSXV
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 46 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Realbotix Corp. is a U.S. based holding company that focuses on humanoid robots and embodied AI systems designed for natural human interaction. Manufactured in the United States, Realbotix's patented technologies enable lifelike facial expressions, fluid movement, vision systems, and advanced social engagement. The Company's platforms are developed for applications in healthcare, education, service industries, and consumer markets.

Company description as published by the issuer via TMX Money.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Realbotix Corp.XBOT TSXV46 Mio. USD
Eastwood Bio-Medical Canada Inc. EBMTSXV 48 Mio. USD
Covalon Technologies Ltd. COVTSXV 44 Mio. USD
Ocumetics Technology Corp. OTCTSXV 43 Mio. USD
BioMark Diagnostics Inc. BUXCSE 43 Mio. USD
Decibel Cannabis Company Inc. DBTSXV 41 Mio. USD
TelyRx Holdings Inc. Subordinate Voting Shares TELYTSX 52 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.